Clinical Trial Update: Irinotecan for Advanced and Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating irinotecan for advanced and metastatic breast cancer; the current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN